Joint Formulary & PAD

Epoprostenol sodium - Inhibition of platelet aggregation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
BNF SPC
R
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Epoprostenol sodium
Indication :
Inhibition of platelet aggregation
Group Name :
Keywords :
antiplatelet, renal dialysis
Brand Names Include :
Flolan
Important Information :

ITU use only - during renal dialysis if heparin is not suitable

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Epoprostenol sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Inhibition of platelet aggregation.

  • No records returned.

Committee Recommendations (0)

  • No records returned.